NAYA Biosciences Corp (NAYA) - Cash Funds per Share

NAYA Biosciences Corp - graphic logo of issuer NAYA

NAYA Biosciences delegates drug production and testing to external contractors to maintain team mobility. The cash per share forecast demonstrates liquidity dynamics, where the value 1.40 captures this metric. NAYA Biosciences is developing unique multispecific antibodies to combat cancer, leveraging a powerful scientific foundation. Independence from the global economy transforms such developments into a resilient defensive asset.

NAYA Biosciences (NAYA) Cash Funds per Share: for the period 07/04/2022 - 04/28/2025

Comprehensive metric breakdowns and analytics for NAYA Biosciences Inc (NAYA)

- cash availability and cash flow indicators:
Summary company analysis:NAYA Biosciences
Manufactured product of NAYA Biosciences Inc.

Developing bispecific antibodies to combat solid tumors requires significant R&D capital expenditures for NAYA Biosciences (NAYA). This metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. By analyzing the current cash per share, an investor determines the intrinsic value of the security and its financial cushion. A stable indicator minimizes the risk of default during prolonged clinical trials, serving as a key solvency indicator for a biopharmaceutical startup.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|AONC: Cash per Share|Cash on Hand per Share BeOne Medicines (BGNE)|Cash Funds per Share Checkpoint Therapeutics, Inc.|Cash per Single Share Elevation Oncology (ELEV)|Cash Funds per Share iCAD Corp (ICAD)|Cash per Single Share Ikena IKNA|Cash per Share NTBL (notablelabs.com)|VIRX - Cash per Single Share|MOR: Cash per Single Share|Cash on Hand per Share ascentage.com